Skip to main content

Advertisement

Open Access
Open Peer Review

This article has Open Peer Review reports available.

How does Open Peer Review work?

Comparison of the anti-inflammatory effects of Cilomilast, Budesonide and a p38 Mitogen activated protein kinase inhibitor in COPD lung tissue macrophages

BMC Pharmacology and Toxicology201213:15

DOI: 10.1186/2050-6511-13-15

Received: 23 February 2012

Accepted: 23 October 2012

Published: 13 November 2012

Back to article

Open Peer Review reports

Pre-publication versions of this article and author comments to reviewers are available by contacting info@biomedcentral.com.

Original Submission
23 Feb 2012 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
22 Aug 2012 Author responded Author comments - Marianne Ratcliffe
Resubmission - Version 3
22 Aug 2012 Submitted Manuscript version 3
22 Oct 2012 Author responded Author comments - Marianne Ratcliffe
Resubmission - Version 4
22 Oct 2012 Submitted Manuscript version 4
Publishing
23 Oct 2012 Editorially accepted
13 Nov 2012 Article published 10.1186/2050-6511-13-15

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article and author comments to reviewers are available by contacting info@biomedcentral.com. All previous versions of the manuscript and all author responses to the reviewers are also available.

You can find further information about the peer review system here.

Authors’ Affiliations

(1)
Personalised Healthcare and Biomarkers, AstraZeneca R&D Alderley Park
(2)
IGD Consultancy Limited

Advertisement